-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-244-fullreport.pdf
December 01, 2019 - Depression Remission or Response for Adolescents and Adults: Report
1
Depression Remission or Response for Adolescents
and Adults
Section 1. Basic Measure Information
1.A. Measure Name
Depression Remission or Response for Adolescents and Adults
1.B. Measure Number
0244
1.C. Measure Description
Pleas…
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-family-engagement/pfeprimarycare/teach-back-slides-final508.pptx
April 04, 2018 - PowerPoint Presentation
Teach-Back
AHRQ
Guide to Improving Patient Safety in Primary Care Settings by Engaging Patients and Families
The Agency for Healthcare Research and Quality, or AHRQ, funded the development of a Guide to Improving Patient Safety in Primary Care Settings by Engaging Patients and Families. A…
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-family-engagement/pfeprimarycare/teach-back-slides-final508.pdf
April 11, 2018 - Teach-Back
Teach-Back
AHRQ
Guide to Improving Patient Safety in
Primary Care Settings by Engaging
Patients and Families
Presenter
Presentation Notes
The Agency for Healthcare Research and Quality, or AHRQ, funded the development of a Guide to Improving Patient Safety in Primary Care Settings by…
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-family-engagement/pfeprimarycare/medicinelist-roleplay-final508.pdf
April 03, 2018 - Create a Safe Medicine List Together: Role Play Scenarios
The Guide to Improving Patient Safety in Primary Care
Settings by Engaging Patients and Families
Create a Safe
Medicine List Together
Role Play Scenario 1
Facilitator Instructions
1. Create props (index cards or post-it notes) to represent the medicine la…
-
ce.effectivehealthcare.ahrq.gov/innovations/will-work/guide1.html
February 01, 2021 - Skip to main content
An official website of the Department of Health and Human Services
Careers
Contact Us
Español
FAQs
Search all AHRQ sites
Search small
Search
Menu
…
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-0245-technical-specifications.pdf
March 01, 2016 - HEDIS Measures for 0245 Depression: Technical Specifications
Depression Screening and Follow-Up for Adolescents and Adults 1
Depression Screening and Follow-Up for Adolescents and Adults (DSF)*
*Adapted with financial support from CMS from a provider-level measure developed by
Quality Insights of Pennsylvania (QI…
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-0244-technical-specifications.pdf
March 01, 2016 - HEDIS Measures for 0244 Depression: Technical Specifications
Depression Screening and Follow-Up for Adolescents and Adults 1
Depression Screening and Follow-Up for Adolescents and Adults (DSF)*
*Adapted with financial support from CMS from a provider-level measure developed by
Quality Insights of Pennsylvania (QI…
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/depression/chipra-246-section-2.pdf
March 01, 2016 - Depression Screening and Follow-Up for Adolescents and Adults
Depression Screening and Follow-Up for Adolescents and Adults 1
Depression Screening and Follow-Up for Adolescents and Adults (DSF)*
*Adapted with financial support from CMS from a provider-level measure developed by
Quality Insights of Pennsylvania (Q…
-
ce.effectivehealthcare.ahrq.gov/practiceimprovement/delivery-initiative/ihs/chapter5.html
December 01, 2017 - ACE inhibitors, antilipemic agents, beta blockers); 2) central nervous system (19.0 percent; e.g., antidepressants
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/Lion-Mangione-Britto.pdf
October 01, 2011 - Adherence: Compared to controls, intervention patients had greater odds
of having used recommended antidepressants
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-245-fullreport.pdf
December 01, 2019 - Utilization of the PHQ-9 to Monitor Depression Symptoms for Adolescents and Adults: Report
Utilization of the PHQ-9 to Monitor Depression
Symptoms for Adolescents and Adults
Section 1. Basic Measure Information
1.A. Measure Name
Utilization of the PHQ-9 to Monitor Depression Symptoms for Adolescents and Adults
…
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/2024-01/noskin-report.pdf
January 01, 2024 - CV agents (31.4%) were
still the most common discrepant drug class, followed by GI agents (8.8%),
antidepressants
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/long-term-care/resources/ontime/fallsprev/ontimefallpxreports-ig.pdf
November 09, 2017 - balance)
History of fall in the last 180 days
Use of psychoactive medications (antipsychotics,
antidepressants … MDS assessment
documents the use of at least one of the following medications:
Antipsychotics
Antidepressants
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-233-fullreport.pdf
August 07, 2018 - Assessing the Availability of the Preconception Component of High-Risk Obstetrical Services by Estimating the Use of Teratogenic Medications Before and During Pregnancy
1
Assessing the Availability of the Preconception
Component of High-Risk Obstetrical Services by
Estimating the Use of Teratogenic Medications B…
-
ce.effectivehealthcare.ahrq.gov/patient-safety/reports/liability/neumiller.html
August 01, 2017 - Similar to our findings, the most common medication classes involved were antibiotics, antidepressants
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-246-fullreport.pdf
December 01, 2019 - Depression Screening and Follow-up for Adolescents and Adults
1
Depression Screening and Follow-up for Adolescents
and Adults
Section 1. Basic Measure Information
1.A. Measure Name
Depression Screening and Follow-up for Adolescents and Adults (Health Plan)
1.B. Measure Number
0246
1.C. Measure Description
P…
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/2024-01/magid-report.pdf
January 01, 2024 - Final Report: Improving Drug Safety
Final Report:
Improving Drug Safety
PI: David Magid, MD, MPH
Co-PI: Marsha Raebel, PharmD
Project Manager: David Brand, MSPH
Project Staff:
Bates, David, MD
Chester, Elizabeth, PharmD
Glasgow, Russell, PhD
Nelson, Kent, PharmD
Palen, Ted, MD, PhD
Platt, Richard, MD, MSc…
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol1/French.pdf
April 27, 2004 - persons are particularly at risk for injuries
associated with the use of certain medications, including antidepressants
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/LomotanDougherty2013.pdf
April 01, 2013 - Pediatric Health Care Quality Measures: Considerations for Pharmacotherapy
Pediatr Drugs
DOI 10.1007/s40272-013-0042-4
LEADING ARTICLE
Pediatric Health Care Quality Measures: Considerations
for Pharmacotherapy
Edwin A. Lomotan • Denise Dougherty
© Springer International Publishing Switzerland (outside th…
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/professionals/clinicians-providers/guidelines-recommendations/tobacco/clinicians/references/meta/meta-analyses-refs.pdf
January 01, 2007 - Treating Tobacco Use and Dependence, 2008 Update: References for Studies in Meta-analyses
1
References for Studies Included in Meta-analyses
Table 6.4. Meta-analysis (1996): Impact of
having a tobacco use status identification
system in place on rates of clinician
intervention with their patients who smoke (n…